EFTA00299800.pdf

09/21/2018 10:18 From: Woodson C. Merrel l M Uebfax Page: 1/13 FAX COVER SHEET fo: Jeffrey Epstein / From: Lisa Company: Company: Woodson Merrell MD PLLC Fax: Phone: Date: 9/21/2018 Pages w/cover: 13 Subject: 9-14-18 LABCORP Lab Results Jeff Comments: EFTA00299800 09/21/2018 10:18 From: Woodson C. Merrell M Uebfax Page: 2/13 LabCorp Patient Report ,!me:, i:1 ", r-lbrU-2371-0 Acct 31143092 Phone: Rte: 68 Convo! ID: F3 [143092 Woodson Merrell EPSTEIN, JEFFREY 44E6AhS( IS: ST New York NY 10065 NEW YORK NY 10021 Patient Details Specimen Details Physician Details D08:01/20/1953 Date toilette& 09/14/2018 1255 Local Ordering: W MERRELL Agely/m/d): 065/07/25 Date received: 09/15/2018 Referring: Gender: M 55N: Date entered: 09/15/2018 ID: MERRELL Patient ID: Date reported: 09/20/2018 0832 ET NPI: 1023153509 General Comments & Additional Information Total Volume: Not Provided Fasting: No Ordered Items CSC WM Differential/Platelet; Comp. Metabolic Panel (14); Urinalysis, Routine; PE+Interp(Ftlx IFE),S; Lipid Panel; Iron and TIBC; Testostetone,Free+Weakly Sound; Vitamin 612 and Folate; FSH and LH; C-Reaclive Protein. Cardiac; Hemoglobin Ale; Prostate-Specific Ag, Serum; TSH; Vitamin D. 25-Hydroxy; Lipoprotein (a): IGF-1; ANA wiReflex; Homooyst(e)ine, Plasma; Prolactin; Thyroxine (T4) Free. Direct. S: Codisol; DHFA-Sulfate; Estradiol; Uric Acid; Phosphorus; LDH: GGT; Amylase; Ferritin. Serum: Insulin: Calcium, Ionized, Serum: Fibrinogen Activity; Magnesium, RBC; Request Problem TESTS RESULT FLAG -UNITS REFERENCE INTERVAL LAB. CSC With Differential/Platelet WBC 5.7 x1083/uL 3.4 - 10.8 01 RBC 4.90 x10E6/uL 4.14 - 5.80 01 Hemoglobin 14.7 g/dL 13.0 - 17.7 01 Hematocrit 42.2 % 37.5 - 51.0 01 MCV 86 IL 79 - 97 01 MCH 30.0 pg 26.6 - 33.0 01 MCHC 34.8 g/dL 31.5 - 35.7 01 RDW 14.6 t 12.3 - 15.4 01 Platelets 242 xl0E3/u1 150 - 379 01 Neutrophils 50 * Not Estab. 01 Lympha 37 * Not Estab. 01 Monocytes 5 t Not Estab. 01 Eos 7 t Not Estab. 01 Satins 1 t Not Estab. 01 Neutrophils (Absolute) 2.8 x10E3/uL 1.4 - 7.0 01 Lymphs (Absolute) 2.1 x10E3/uL 0.7 - 3.1 01 Monocytes(Absolute) 0.3 x10E3/uL 0.1 - 0.9 01 Eos (Absolute) 0.4 xl0E3/uL 0.0 - 0.4 01 Baso (Absolute) 0.0 xl0R3/uL 0.0 - 0.2 01 Immature Granulocytes 0 t Not Estab. 01 Immature Grans (Abs) 0.0 x10E3/uL 0.0 - 0.1 01 Comp. Metabolic Panel (14) Glucose 128 High mg/dL 65 - 99 01 Sample is lipemic. This may cause spurious increases in TBili, DBili, AST, ALT, and =X (if ordered). Clinical correlation indicated. Specimen received hemolyzed. Clinical correlation indicated. Datehmed:09/20/160032LT FINAL REPORT Page I of 6 This document contains private and cu.t Jential heallf rotected by state and federal law. 01995-2018 Laboratory Corporation of America* Holdings If you have waived this document In error. please tall All lights Reserved • Enttrprhe Report Versiort 1.00 EFTA00299801 09/21/2818 10:18 From: Woodson C. Merrell M Webfax Page: 3/13 IQ LaityOrp Patient Report Patiaat:EPSTEIN,MYRIEY DOB:01/20/1953 Spocirnen ID: 257-4110-2371-0 Patient ID: Control ID: F5831143092 Date collected: 09/14/2018 1255 LOW TESTS RESULT FLAG UNITS REFERENCE INTERVAL TAB BUN 22 mg/dL 8 - 27 01 Creatinine 0.96 mg/dL 0.76 - 1.27 01 eGFR If NonAfricn Am 83 mL/min/1.73 >59 eGPR If Africn Am 95 mL/min/1.73 >59 BUN/Creatinine Ratio 23 10 - 24 Sodium 138 mmol/L 134 - 144 01 Potassium 4.2 mmol/L 3.5 - 5.2 01 Sample is lipemic. This may cause spurious increases in TBili, DBili, AST, ALT, and UIBC (if ordered). Clinical correlation indicated. Specimen received hemolyzed. Clinical correlation indicated. Chloride 102 mmol/L 96 - 106 01 Carbon Dioxide, Total 20 mmol/L 20 - 29 01 Calcium 9.4 mg/dL 8.6 - 10.2 01 Protein, Total 6.7 g/dL 6.0 - 8.5 01 Albumin 4.3 g/dL 3.6 - 4.8 01 Globulin, Total 2.4 g/dL 1.5 - 4.5 A/G Ratio 1.8 1.2 - 2.2 Bilirubin, Total 0.3 mg/dL 0.0 - 1.2 01 Alkaline Phosphates. 71 IU/L 39 - 117 01 AST (SOOT) 26 IU/L 0 - 40 01 The specimen was lipemic. The lipemia was cleared by ultracentrifugation before testing. However HDL, direct LDL, cholesterol and triglyceride (if ordered) were performed prior to ultracentrifugation. ALT (SGPT) 37 ItY/L 0 44 01 Urinalysis, Routine Urinalysis Gross Exam 01 Specific Gravity 1.027 1.005 - 1.030 01 pH 5.5 5.0 - 7.5 01 Urine-Color Yellow Yellow 01 Appearance Clear Clear 01 NEC Esterase Negative Negative 01 Protein Negative Negative/Trace 01 Glucose Negative Negative 01 Ketones Negative Negative 01 Occult Blood Negative Negative 01 Bilirubin Negative Negative 01 Urebilinogen,Semi-On 0.2 EU/dL 0.2 - 1.0 01 Nitrite, Urine Negative Negative 01 Microscopic Examination Microscopic follows if indicated. 01 PE+Interp(Rfx IFE),S Date Issued. 09120,18 0832 ET FINAL REPORT Page? of 6 This document contains Private and conSiental health information tected by state and federal law. O 995-2018 Laboratory Coiporation of Americas Holdings If you have receved this document in error. please cal AlRights Reserved - fritorodse Reedit Ver3$OO: 1.00 EFTA00299802 09/21/2018 10:18 From: Woodson C. Merrell M Webfax Page: 4/13 LabCorp Patient Report Patient: EPSTEIN, HI FREY Specimen ID: 257-480-2371D DOLS:01/20/1953 Patient ID: Control ID: F51B1143092 Data collected: 09/14/2018 1255 Local TESTS RESULT FLAG UNITS REFERENCE INTERVAL LAB Albumin 4.0 g/dL 2.9 - 4.4 01 Alpha-1-Globulin 0.1 g/dL 0.0 - 0.4 01 Alpha-2-Globulin 0.8 g/dL 0.4 - 1.0 01 Beta Globulin 0.9 g/dL 0.7 - 1.3 01 Gamma Globulin 0.9 g/dL 0.4 - 1.8 01 M-Spike Not Observed g/dL Not Observed 01 Globulin, Total 2.7 g/dL 2.2 - 3.9 A/G Ratio 1.5 0.7 - 1.7 Please note: 01 Protein electrophoresis scan will follow via computer, mail, or courier delivery. Interpretation(See Below) 01 The SPE pattern appears essentially unremarkable. Evidence of monoclonal protein is not apparent. PDF 01 Lipid Panel Cholesterol, Total 234 High mg/dL 100 - 199 01 Tr1slycerides 1714 Alert mg/dL 0 - 149 01 Results confirmed on dilution. HDL Cholesterol 19 Low mg/dL >39 01 VLDL Cholesterol Cal mg/dL 5 - 40 The calculation for the VLDL cholesterol is not valid when triglyceride level is >400 mg/dL. LDL Cholesterol Cale mg/dL 0 - 99 Triglyceride result indicated is too high for an accurate LDL cholesterol estimation. Iron and TIBC Iron Bind.Cap.(TIBC) 320 ug/dL 250 - 450 UIBC 252 ug/dL 111 - 343 01 Iron 68 ug/dL 38 - 169 01 Iron Saturation 21 t 15 - 55 Testosterone,Free+Weakly Bound Testosterone, Serum 140 Low ng/dL 264 - 916 01 Adult male reference interval is based on a population of healthy nonobese males (HM/ <30) between 19 and 39 years old. Travison, et.al. /CHM 2017,102;1161-1173. PMID: 28324103. Testost., V Free,Weakly Bound 9.0 - 46.0 02 Test Not Performed. Specimen is lipemic. Testost., F+W Bound 40.0 - 250.0 Unable to calculate result since non-numeric result obtained for component test. Vitamin B12 and Folate oatossued:o9nwisone FINAL REPORT Page 3 016 Thisdocument contains private and confidential peak °woad by stele end federal law. 01995.2018 Iahoratoryfonsoretion of America, Hoe:lines If you have received this document in error, please tel Al nights Reserved -Enterprise Repon Version 101 EFTA00299803 09/21/2018 10:18 From: Woodson C. Merrell M Uebfax Page: 5/13 LabCorp Patient Report Patient: EPSTEIN, JEFFREY Specimen ID: 257-480-23/1-0 DOB: 01/20/1953 Patient ID: Cmitmlitkig01143092 Date collected: 09/14/2018 1255 Local TESTS RFEULT FLAG UNITS REFERENCE INTERVAL LAB Vitamin B12 463 pg/mL 232 - 1245 01 Folate (Folic Acid), Serum 4.4 ng/mL >3.0 01 Note: 01 A serum folate concentration of less than 3.1 ng/mL is considered to represent clinical deficiency. FSH and LH LH 3.7 mIU/mL 1.7 - 8.6 01 FSH 4.4 mIU/mL 1.5 - 12.4 01 C-Reactive Protein, Cardiac 1.56 mg/L 0.00 - 3.00 01 Relative Risk for Future Cardiovascular Event Low <1.00 Average 1.00 - 3.00 High >3.00 Hemoglobin Ale Hemoglobin Aic 5.5 § 4.6 - 5.6 01 Please Note: 01 Prediabetes: 5.7 - 6.4 Diabetes: >6.4 Glycemic control for adults with diabetes: <7.0 Prostate-Specific Ag, Serum Prostate Specific Ag, Serum 0.7 ng/mL 0.0 - 4.0 01 Roche ECLIA methodology. According to the American Urological Association, Serum PSA should decrease and remain at undetectable levels after radical prostatectomy. The AUA defines biochemical recurrence as an initial PSA value 0.2 ng/mL or greater followed by a subsequent confirmatory PSA value 0.2 ng/mL or greater. Values obtained with different assay methods or kits cannot be used interchangeably. Results cannot be interpreted as absolute evidence of the presence or absence of malignant disease. TSH 1.290 uIU/mL 0.450 - 4.500 01 Vitamin D, 25-Hydroxy 20.2 Low ng/mL 30.0 - 100.0 01 Vitamin D deficiency has been defined by the Institute of Medicine and an Endocrine Society practice guideline as a level of serum 25-OH vitamin D less than 20 ng/mL (1,2). The Endocrine Society went on to further define vitamin D insufficiency as a level between 21 and 29 ng/mL (2). 1. IOM (Institute of Medicine). 2010. Dietary reference intakes for calcium and D. Washington DC: The National Academies Press. 2. Holick MP, Hinkley NC, Bischoff-Ferrari HA, et al. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. JCEM. 2011 Jul; 96(7):1911-30. Date Issued: 09/20/180832 LT FINAL REPORT Page 406 This document contains private and con9dentill hat. f 0:feted by stete and federal law. 0 1995-2018 Laboratory Corporation of America* Haling, II you have received this document in error, please All Rights Relieved • Entir9rIlle Neon Vermeer 1.00 EFTA00299804 09/21/2018 10:18 From: Woodson C. Merrell M Uebfax Page: 6/13 LfaliCorp Patient Report Patient: EPSTEIN, JEEFREY Specimen ID: 257-480-1371-0 DOB:01/20/1953 Patient ID: Contra ID: F6831143092 Date collected: 09/14/2018 1255 Local TESTS RESULT FLAG UNITS REFERENCE INTERVAL ISR Lipoprotein (a) 20 nmol/L <75 Note: Values greater than or equal to 75 nmol/L may indicate an independent risk factor for CHD, but must be evaluated with caution when applied to non-Caucasian populations due to the influence of genetic factors on Lp(a) across ethnicities. I0E-1 Insulin-Like Growth Factor I 137 ng/na, 49 - 188 02 ANA w/Reflex ANA Direct Negative Negative 01 Homocyst(e)ine, Plasma 14.9 umol/L 0.0 - 15.0 01 Prolactin 3.9 Low ng/ntL 4.0 - 15.2 01 Thyroxine (T4) Free, Direct, S T4,Free(Direct) 1.05 ng/dL 0.82 - 1.77 01 Cortisol 3.7 ug/dL 01 Cortisol AM 6.2 - 19.4 Cortisol PM 2.3 - 11.9 DEKA-Sulfate 181.8 ug/dL 30.9 - 295.6 02 Estradiol 28.3 pg/mL 7.6 - 42.6 01 Roche ECLIA methodology Uric Acid Uric Acid 6.8 mg/dL 3.7 - 8.6 01 Please Note: 01 Therapeutic target for gout patients: <6.0 Phosphorus 3.6 mg/dL 2.5 - 4.5 01 LDH 213 IU/L 121 - 224 01 GGT 25 IU/L 0 - 65 01 Amylase 37 U/L 31 - 124 01 Ferritin, Serum 104 ng/mL 30 - 400 01 Insulin 47.2 High oIli/mI 2.6 - 24.9 01 Date Issued. 09120/18 0837 ET FINAL REPORT Page 5 of 6 Thh doawrent contains private end ccnficlential heat otected by state and federal law. 1995-2018 LaboratoryCorporation of Ameticao holdings If you have tecelved IN, document in error, plea. call All lights noatived Enteeprhe Report Venlorc 1.00 EFTA00299805 09/21/2018 10:18 From:SOIS Woodson C. Merrel l M Uebfax Page: 7/13 RLabCorp Patient Report Patient: EPSTEIN, JEFFREY Specimen ID: 257-48C-23710 D0S:01/20/1953 PatlientIM Control ID:15831143092 Date collected: 09/114,2018 1255 Local TESTS RESULT FLAG UNITS REFERENCE INTERVAL LAB Calcium, Ionized, Serum 5.3 mg/dL 4.5 -- 5.6 01 Fibrinogen Activity 330 mg/dL 193 - 507 01 Specimen was ultracentrifuged before testing to remove extreme lipemia. Results should be interpreted with caution. Magnesium, RBC 5.4 mg/dL 4.2 - 6.8 02 Plasma NOT separated from cells; may falsely decrease RBC Magnesium levels. Request Problem 02 Test Not Performed. Specimen is lipemic. TEST: 143257 Testost., % Pree+Weakly Bound Panel: 143255 1 01 RN LabCorp Raritan Dir. Nautili B Reyes, MD 69 First Avenue, Raritan, NJ 08889-1800 02 BN LabCorp Burlington Dir. William F Hancock. MD 1447 York Court, Burlington, NC 27215-3361 For inquiries. the physician may contact Branch: Lab: Date Issued; 09120/180832 ET FINAL REPORT Page 6 of 6 This document contains privateandconfidential health Inforrnaton tested by state and federal law. o 1995.2018 Laboratory Corporation of Amerce° Holdings If you have received this document in era, pleats call All Monts Reserved • Enteepnte Report Venion, l.00 EFTA00299806 09/21/2818 18:18 From: iliddeigliWoodson C. Merrell M Uebfax Page: 8/13 Laboratory Corporation of America Special Chemistry Department Raritan New Jersey Serum Protein Electrophoresis Serum Proteins PE Gel T44577 Sample 32 09/17/2018 15:43:01:31 Accession Number 257480237106 Physician ID Patient Name EPSTEIN, JEFFREY Account Address 1 Total Protein 6.7 Account Address 2 44 E 67th St Patient ID Account Addross 3 New York, NY 10065 Birthdate 1/20/1953 Account No./Name 31143092-Woodson Merrell IIInh2574802371 11111]11 06 111 Fenton % gidIRange Atom& 60.3 4.0 2.9 to 4.4 Alpha.1 2.0 0.1 0.0 to 0.4 Alpha•2 11.7 0.8 0.4 to 1.0 Bea 13.3 0.9 0.7 to 1.3 Gamma 12.7 0.9 0.4 to 1.8 Twal 6.7 6.0 to 8.5 The SPE pattern appears essentially unremarkable. Evidence of monoclonal protein is not apparent. EFTA00299807 09/21/2618 10:18 From: Woodson C. Merrell M Uebfax Page: 9/1j "WI M P Patient Report Specimen ID: 257-480-22300 Acct d: 31143092 Phone: Rte: 68 Control ID: F4931143092 Woodson Merrell EPSTEIN,JEFFREY 44 E 67th St 9E 71STST New York NY 10065 NEW YORK NY 10021 Patient Details Specimen Decals Physician Details DOB: 01/2O/1953 Dam coRomed: 09/14/2018 1255 Local Ordering: Vd MERRELL AgeNSINdt %SAMS Date mollified: 09/152018 Referring: Conan: M 55N: Date entered: 09/15/2018 ID: Patient 0: E012053 Ono omens* 09/19/2018 0610 ET NPI: 1023153509 Ordered Items Vitamin 86. Plasma TESTS RES12:7 FLAG UNITS REFERENCE INTERVAL LAE Vitamin B6, Plasma Vitamin B6 7.2 ug/L 5.3 - 46.7 01 Disclaimer: 01 This test was developed and its performance characteristics determined by LabCorp. It has not been cleared or approved by the Food and Drug Administration. I 01 BN LabCorp Burlington DirWillarnFHancock.MD 1447 York Court. Burlington, NC 27215-3361 For inquiries, the physician may contact Branch: Lab: Date ISSued 09/21/18 0838 LT ANAL REPORT Page 1011 This document contains private and confdential host, informatIon proleceed by state and federM taw. O 1945-2018 tabstatery Corporation of America* Flokengs If you hoe oceNed th)C~nit in'Mr MdAeaw , cat Al Rights Reserved • Ent/toast Reran Yenta& 1.00 EFTA00299808 09/21/2818 10:18 From: Woodson C. Merrell M Uebfax Page: 10/13 OLabeforp Patient Report Specimen ID: 257-480-2232-0 Acct a: 31143092 Phone: Rte: 68 Control ID: F SA31143092 Woodson Merrell EPSTEIN, JEFFREY 44 E 67th St New York NY 10065 111111111.111111IIIIIIIIIIIIIIIIII'llIllalll'IIIIIIIIIIIIIIIIIII Patient Details Specimen Details Physician Details DOR:01/20/1953 Date collected: 09/14/2018 1255 Local Ordering: Agety/m/d): 065/07/25 Date received: 09/15/2018 Referring: Gender M SSN: Date entered: 09/15/2018 ID: MERRELL P.sticut tO. one reamed: miasma WPM tl NPI: General Comments & Additional Information Total Volume: N0t Provided Fasting: No Ordered Items CaaPTH Intact TESTS RESULT FLAG UNITS REFERENCE INTERVAL LAB Ca+PIE Intact Calcium 9.5 mg/dL 8.6 - 10.2 01 Specimen received hemolyzed. C cal correlation indicated. PTE, Intact High In/mL 15 - 65 01 Intact PTH 01 Interpretation Intact PTH Calcium (pg/mL) (mg/dL) Normal 15 - 65 8.6 - 10.2 Primary Hyperparathyroidism >65 >10.2 Secondary Hyperparathyroidism >65 <10.2 Non-Parathyroid Hypercalcemia <65 >10.2 Hypoparathyroidism <15 < 8.6 Non-Parathyroid Hypocalcemia 15 - 65 e 8.6 01 RN labCorp Raritan Dr: Aracel B Reyes. MO 69 First Avenue Raritan NJ 08869-1800 For Inquiries, the physician may contact Brandi: Lab: Daze Issued: 09/17!180916 ET FINAL REPORT Page 1 of 1 11-in document contains private and confickinitiai health Wombat:on tectied by state and federal law. O1995-20Th Laboratory Colporaoon of ArnencasHoldIngs If you have mewed :his document it error, please call MIRights Reserved Enterprise bornWill= 140 EFTA00299809 09/21/2018 10:18 From: Woodson C. Merrel l M Uehfax Page: 11/13 Pir,Labrporp Patient Report Specimen ID: 257480,2715-0 Acct a: 31143092 Phone: Rte 68 Control ID: END31143092 Woodson Merrell EPSTEIN,JEFFREY 44 E 67th St 9E715TST New York NY 10065 NEW YORKNY 10021 tuhhhhlPdurPhrllllllllhlhPnhrllhhPPllllrllltllllll Patient Details Specimen Details Physician Details DOB:01/20/1953 Date collected: 09/14/2018 1255 Local Otclerniri ,,', MI HP II Age(y/m/d): 065/07/25 Date received: 09/15/2018 Refer, ing. Gender: M SSN: Date entered: 09/15/2018 ID: Patient ID: Date reported 09/18/2018 0610 ET r4 of: 'C23:53509 General Comments A Additional Information Total Volume: Not Provided Fasting: No Ordered Items Chlamydia/GC AmplIkation. Panel 083935; HCV Ab wlRflx to Venficaton: RPR, Rix On RPR/Confirm TP TESTS RESULT FLAG UNITS REFERENCE INTERVAL •"LAB Chlamydia/GC Amplification Chlamydia trachomatis, NAA Negative Negative 01 Neisseria gonorrhoeae, NAA Negative Negative 01 Panel 083935 HIV Screen 4th Generation wRfx Non Reactive Non Reactive 01 HCV Ab w/Rflx to Verification HCV Ab <0.1 s/co ratio 0.0 0.9 01 Comment: 01 Non reactive HCV antibody screen is consistent with no HCV infection, unless recent infection is suspected or other evidence exists to indicate HCV infection. RPR, Rfx Qn RPR/Confirm TP RPR Non Reactive Non Reactive 01 01 RN LabCorp Raritan Dir: Aracek B Reyes. MO 69 First Avenue, Raritan, NJ 08869-1800 For Inquiries, the physician may coning Branch: Lab: Date Issued: 09/18/181053 ET FINAL REPORT Page I el I This Occument contains pitate andcoorticiernial health information blood by state andtederal iggS-2018 Latc,r atm)/ Corpnretion of Arft-1, '.Cei H0idlfrip if you have received this document in err,. please cal All Hight R Rewrted Enterprise Ripon Version 1O0 EFTA00299810 09/21/2018 10:18 From: Woodson C. Merrel l M Uebfax Page: 12/13 Patient Report Specimen lb: : )7-480-2542-0 Acct #: 31143092 Phone: RN: 68 Control iD: P.../:31143092 Woodson Merrell EPSTEIN, JEFFREY 44 E 67th St 9 E 71ST ST New York NY 10065 NEW YORK N'T I i Patient Details Specimen Details Physician Details DOB:01/20/1953 Date collected: 09/14/2018 1255 Local Ordering: W mERPEL1 Agely/mId):065/07/25 Date received: 09/15/2018 Referring: Gender: M SSN: Date entered: 09/15/2018 ID: MERRELL Patient ID: Date reported: 09/18/2018 0823 ET NPR 1023153509 General Comments & Additional Information Total Volume: Not Provided Fasting: No Ordered Items Inc, Whole Blood TESTS RISPLT Lplaa UNITS REFERENCE INTERVAL LAB Zinc, Whole Blood 01 BN LabCorp Burlington Dir. William F I lancock. MD 1447 York Coun Burlington, NC 27215-3381 For inquiries, me physician may contact Branch: Lab: Date Issued: 09/18.i81053 ET FINAL REPORT Page I of t This docurnem contains private and confidential health • t' n tected bystale and federal law 1995-2015 taboiatoryCorporalon of Arrieika•Holdinps d you have °Keyed thn document in error, *ate 49 All nights Reatived - Imerestisii Bataan WNW. 1.00 EFTA00299811 09/21/2818 10:18 From: Woodson C. Merrell M Wehfax Page: 1J/li Labegorp